Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4519 On Other Exchanges
Symbol
Exchange
4519 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michio Ishizuka

Audit & Supervisory Board Member, Chugai Pharmaceutical Co. Ltd.
AgeTotal Calculated CompensationThis person is connected to 22 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Mr. Michio Ishizuka serves as a Full-Time Audit & Supervisory Board Member of Chugai Pharmaceutical Co. Ltd.

Corporate Headquarters*

1-1 Nihonbashi-Muromachi 2-Chome
Tokyo, -- 103-8324

Japan

Phone: 81 3 3281 6611
Fax: 81 3 3281 6607

Board Members Memberships*

Audit & Supervisory Board Member

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4519:JP ¥3,765.00 JPY 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Karl-Ludwig Kley Chairman of Executive Board and Chief Executive Officer
Merck KGaA
€6.6M
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Strategy Committee and Chairman of Appointments & Governance Committee
Sanofi
€700.0K
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
$1.1M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHUGAI PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.